Open Medicine10.1515/med-2016-00032016111Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case reportTao Wang, Ruimin Wang, Zhouhuan Dong, Naichao Liang, Ping Chang,
Chest10.1378/chest.199456720141464591ANon-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation: Response to ChemotherapyUthara Vijai Kumar,
Brain Metastases from Primary Tumors10.1016/b978-0-12-801419-6.00005-7201569-75Brain Metastasis from Non-Small Cell Lung Cancer: Use of Epidermal Growth Factor Receptor and HER2 Status for Targeted TherapyHyo Sup Shim, Ja Seung Koo, Se Hoon Kim,
Cancer Treatment Reviews10.1016/j.ctrv.2013.05.0012013398839-850Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patientsMonic Roengvoraphoj, Gregory J. Tsongalis, Konstantin H. Dragnev, James R. Rigas,
Lung Cancer10.1016/0169-5002(95)90545-61995132193Immunohistochemical evaluatin of E-cadherin and epidermal growth factor receptor in non-small cell lung cancer,
Lung Cancer10.1016/0169-5002(89)90104-9198952-3108Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer,
Lung Cancer10.1016/0169-5002(94)93777-x1994112Epidermal growth factor receptor (EGFR) in non small cell lung cancer (NSCLC),
Lung Cancer10.1016/s0169-5002(13)70022-9201379S822 Epidermal growth factor receptor (EGFR) mutation testing in non small cell lung cancer – the New Cross Hospital experienceL. Dunphy, N. Murukesh, D.R. Ferry,
Journal of Thoracic Oncology10.1097/jto.0b013e318174e981200836S143-S145First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in EGFR Mutation; Positive Non-small Cell Lung Cancer PatientsLecia V. Sequist,
Lung Cancer10.1016/0169-5002(94)92212-81994115-6430-431Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852,